Medicine Recommendations

LSCMMG

Green

BwD

Green

Green

Green

Green

Green

Green

Green

Green

Apixaban

Date Posted: 01 - Jul - 2014

BNF chapter: Cardiovascular system

Expand/Collapse

Prevent of stroke and systemic embolism in people with nonvalvular atrial fibrillation (NICE TA275)

NICE TA275 - Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Apixaban

Date Posted: 01 - Jul - 2015

BNF chapter: Cardiovascular system

Expand/Collapse

Treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (NICE TA 341)

NICE TA 341 - Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism

Red

Red

Red

Red

Red

Red

Red

Red

Red

Apixaban

Date Posted: 01 - Jul - 2014

BNF chapter: Cardiovascular system

Expand/Collapse

Prevention of venous thromboembolism after total hip or knee replacement in adults (NICE TA245)

NICE TA245 - Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults

Amber 1

Amber 1

Amber 1

Amber 1

Amber 1

Amber 1

Amber 1

Amber 1

Amber 1

Apomorphine

Date Posted: 01 - Jan - 2017

BNF chapter: Central nervous system

Expand/Collapse

Parkinson's disease

Red

Red

Red

Red

Red

Red

Red

Red

Red

Apremilast

Date Posted: 01 - Dec - 2016

BNF chapter: Skin

Expand/Collapse

Moderate to severe plaque psoriasis (NICE TA419)

NICE TA419 - Apremilast for treating moderate to severe plaque psoriasis

Red

Red

Red

Red

Red

Red

Red

Red

Red

Apremilast

Date Posted: 01 - Mar - 2017

BNF chapter: Musculoskeletal system

Expand/Collapse

Active Psoriatic Arthritis (NICE TA433)

NICE TA433 - Apremilast for treating Active Psoriatic Arthritis

Grey N.P.

Pending

Grey

Pending

Pending

Grey

Pending

Green

Pending

Aquamax ®

Date Posted: 01 - Apr - 2013

BNF chapter: Skin

Expand/Collapse

Emollient preparation

Red

Pending

Red

Red

Pending

Red

Red

Amber 1

Red

Aripiprazole

Date Posted: 01 - Oct - 2013

BNF chapter: Central nervous system

Expand/Collapse

Bipolar disorder in Adolescents (NICE TA292)

NICE TA 292 - Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder

Amber 1

Pending

Amber 1

Amber 1

Pending

Amber 1

Amber 1

Amber 1

Amber 1

Aripiprazole

Date Posted: 01 - Oct - 2013

BNF chapter: Central nervous system

Expand/Collapse

Bipolar disorder in Adults

Red

Red

Red

Red

Red

Red

Red

Red

Red

Aripiprazole Prolonged-Release-Suspension-Injection

Date Posted: 01 - Jan - 2016

BNF chapter: Central nervous system

Expand/Collapse

Maintenance treatment of schizophrenia in adult patients

Amber 1

Pending

Amber 1

Amber 1

Pending

Amber 1

Amber 1

Amber 1

Amber 1

Aripiprazole

Date Posted: 01 - May - 2013

BNF chapter: Central nervous system

Expand/Collapse

Treatment of Schizophrenia in adults. Treatment of Schizophrenia in people aged 15 to 17 years (NICE TA213)

NICE TA213 - Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Black

Pending

Black

Black

Pending

Black

Black

Black

Pending

Asenapine

Date Posted: 01 - May - 2013

BNF chapter: Central nervous system

Expand/Collapse

Acute Mania

Green

Pending

Green

Green

Pending

Green

Green

Pending

Pending

Aspirin

Date Posted: 01 - Jan - 2016

BNF chapter: Cardiovascular system

Expand/Collapse

Secondary Prevention of stroke (as per LSCMMG Guidelines)

Green

Pending

Green

Green

Pending

Green

Green

Green

Green

Aspirin dispersible

Date Posted: 01 - May - 2016

BNF chapter: Central nervous system

Expand/Collapse

Acute Migraine

Green

Green

Green

Green

Green

Green

Green

Green

Green

Atectura Breezhaler (indacterol/mometasone)

Date Posted: 12 - Sep - 2022

BNF chapter: Respiratory system

Asthma

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Atogepant

Date Posted: 21 - Aug - 2024

BNF chapter: Central nervous system

Expand/Collapse

Preventing migraine (NICE TA973)

NICE TA973 - Atogepant for preventing migraine

Amber 1

Amber 1

Amber 1

Amber 1

Amber 1

Amber 1

Amber 1

Amber 1

Amber 1

Atomoxetine

Date Posted: 01 - May - 2013

BNF chapter: Central nervous system

Expand/Collapse

ADHD

NICE guideline NG87: Attention deficit hyperactivity disorder: diagnosis and management

MHRA Drug Safety Update - Atomoxetine: increases in blood pressure and heart rate

LSCMMG

Green (R)(Restricted)

BwD

Green (R)(Restricted)

BP

Green (R)(Restricted)

CSR

Green (R)(Restricted)

EL

Green (R)(Restricted)

FW

Green (R)(Restricted)

GP

Green (R)(Restricted)

MB

Green (R)(Restricted)

WL

Green (R)(Restricted)

Avanafil

Date Posted: 31 - Aug - 2023

BNF chapter: Genito-urinary system

Expand/Collapse

Treatment of erectile dysfunction in adult men who are unable to tolerate sildenafil and tadalafil

Red

Red

Red

Red

Red

Red

Red

Red

Red

Avatrombopag

Date Posted: 13 - Jul - 2020

BNF chapter: Blood and Nutrition

Expand/Collapse

Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure (TA 626)

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Aviptadil / Phentolamine Mesilate Injection

Date Posted: 01 - Jul - 2017

BNF chapter: Genito-urinary system

Expand/Collapse

Breadcrumb

Medicine Recommendations

Prevent of stroke and systemic embolism in people with nonvalvular atrial fibrillation (NICE TA275)

Treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (NICE TA 341)

Prevention of venous thromboembolism after total hip or knee replacement in adults (NICE TA245)

Parkinson's disease

Moderate to severe plaque psoriasis (NICE TA419)

Active Psoriatic Arthritis (NICE TA433)

Emollient preparation

Bipolar disorder in Adolescents (NICE TA292)

Bipolar disorder in Adults

Maintenance treatment of schizophrenia in adult patients

Treatment of Schizophrenia in adults. Treatment of Schizophrenia in people aged 15 to 17 years (NICE TA213)

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Acute Mania

Secondary Prevention of stroke (as per LSCMMG Guidelines)

Acute Migraine

ADHD

For the symptomatic treatment of erectile dysfunction in adult males due to neurogenic, vasculogenic, psychogenic, or mixed aetiology.